Patrick K Reville, MD, MPH¹, Hagop Kantarjian, MD², Gautam Borthakur, MD¹, Musa Yilmaz, MD³, Naval Daver, MD¹, Nicholas Short, MD⁴, Courtney D. DiNardo, MD, MSCE¹, Steven M. Kornblau, MD¹, Naveen Pemmaraju, MD¹, Nitin Jain, MD³, Yesid Alvarado, MD¹, Prithviraj Bose, MD⁵, Elias Jabbour, MD¹, Kelly S. Chien, MD¹, Hussein A Abbas, MD, PhD¹, Lucia Masarova, MD¹, Sa A Wang, MD^6*, Rebecca S. S Tidwell, MS^7*, Michael Andreeff, MD, PhD¹, Guillermo Garcia-Manero, MD⁸, Marina Konopleva, MD, PhD¹, Farhad Ravandi, MD¹ and Tapan M. Kadia, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁵The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Giovanni Marconi, MD¹, Alfonso Piciocchi, MS^2*, Ernesta Audisio^3*, Giorgio Priolo^4*, Cristina Papayannidis, MD, PhD⁵, Maurizio Martelli, MD^6*, Francesca Paoloni^2*, Roberto Massimo Lemoli, MD^7,8*, Monica Bocchia, MD^9*, Francesco Lanza, MD^10*, Albana Lico, MD^11*, Fabio Ciceri, MD^12*, Matteo G. Della Porta, MD^13*, Marco Frigeni^14*, Luisa Giaccone, MD, PhD^15*, Germana Beltrami, MD^16*, Erika Borlenghi, M.D.^17*, Maria Chiara Di Chio, MD^18*, Carmine Selleri, Prof.¹⁹, Enrico Crea^2*, Irene Urbino, MD^20*, Chiara Sartor, MD PhD^21*, Clara Minotti, MD^22*, Fabio Guolo, MD^23,24*, Edoardo La Sala, MSc^25*, Jacopo Nanni, MD^21*, Giorgia Simonetti, PhD^26*, Maria Teresa Bochicchio^26*, Giuseppe Saglio, MD, PhD²⁷, Adriano Venditti, MD²⁸, Marco Vignetti, MD^29*, Paola Fazi, MD^2* and Giovanni Martinelli, MD³⁰

¹IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori “Dino Amadori”(IRST),, Meldola, Italy
²GIMEMA Foundation, Rome, Italy
³TORINO CITTÀ DELLA SALUTE E DELLA SCIENZA, Torino, Italy
⁴Haematology 2 - A.O.U San Giovanni Battista, Turin, ITA
⁵IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy, Bologna, Italy
⁶Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
⁷University of Genoa, Clinic of Hematology, Department of Internal Medicine (DiMI), Genoa, Italy
⁸IRCCS San Martino Hospital, Genoa, Italy
⁹Hematology, University of Siena, Azienda Ospedaliera Universitaria Senese, Siena, Italy, Siena, Italy
¹⁰Division of Hematology, Onco-hematologic Department, AUSL della Romagna, Ravenna, Italy
¹¹Hematology and Clinical Immunology, Department of Medicine, AULSS 8 BERICA - OSPEDALE DI VICENZA, Vicenza, Italy
¹²Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
¹³Cancer Center IRCCS Humanitas Research Hospital, Milan, Italy, Italy
¹⁴Ospedale Papa Giovanni XXIII, Bergamo, ITA
¹⁵Department of Oncology and Hematology, SSD Stem Cell Transplant Center, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy
¹⁶IRCCS Ospedale Policlinico San Martino, Ematologia e terapie cellulari, Genoa, Italy
¹⁷Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
¹⁸Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
¹⁹Department of Medicine, Surgery, and Dentistry, University of Salerno, Baronissi, Italy
²⁰Department of Oncology and Hematology, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy
²¹Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
²²Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
²³Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino, Genova, Italy
²⁴Clinic of Hematology, Department of Internal Medicine (DiMI), Policlinico San Martino, IRCCS per l’Oncologia, University of Genoa, Genoa, Italy
²⁵Gruppo Italiano Malattie Ematologiche Dell’Adulto GIMEMA, Roma, Italy
²⁶Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
²⁷Divisione Universitaria di Ematologia e Terapie Cellulari, A.O. Ordine Mauriziano, Turin, Italy
²⁸Università Tor Vergata, Dipartimento di Biomedicina e Prevenzione, Rome, Italy, Italy
²⁹GIMEMA Research Foundation, Rome, Italy
³⁰IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori", Meldola, Italy

Chong Chyn Chua, MBBS, FRACP, FRCPA^1,2, Sun Loo, MBBS, FRACP, FRCPA^1,3,4, John Reynolds, PhD^3*, Ing S Tiong, FRACP, FRCPA, MPhil^3,5, Chun Yew Fong, MBBS, PhD, FRACP, FRCPA⁶, Stephen B Ting, MBBS, FRACP, FRCPA, PhD^7*, Shaun Fleming, FRACP FRCPA^3*, Andrew W Roberts, MBBS, PhD^4,8 and Andrew H Wei, MBBS, PhD^1,3,9

¹The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia
²Department of Haematology, The Alfred Hospital and Monash University, Melbourne, VIC, Australia
³The Alfred Hospital and Monash University, Melbourne, VIC, Australia
⁴Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
⁵Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, VIC, Australia
⁶Austin Health and Olivia Newton John Cancer Research Institute, Melbourne, VIC, Australia
⁷Department of Haematology, Eastern Health and Monash University, Melbourne, VIC, Australia
⁸The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
⁹Department of Clinical Haematology, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, VIC, Australia

Olga Salamero, MD^1*, Tim C.P Somervaille, PhD FRCP FRCPath², Antonieta Molero, MD^3*, Evelyn Acuña-Cruz, MD^4*, Jose A. Perez-Simon, MD, PhD⁵, Rosa Coll, MD^6*, Montserrat Arnan, MD, PhD^7*, Brayan Merchan^8*, Ana Perez, MD^3*, Isabel Cano^4*, Rebeca Rodríguez-Veiga^4*, Mabel Arevalo, PhD^9*, Sonia Gutierrez^9*, Carlos Buesa, PhD^9*, Douglas V Faller, MD, PhD¹⁰, Francesc Bosch, MD, PhD¹ and Pau Montesinos, MD, PhD^4*

¹Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
²Haematology Department, The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
³Department of Hematology, University Hospital Vall d’Hebron, University Autonoma of Barcelona (UAB), Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
⁴Hospital Universitari i Politècnic La Fe, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain
⁵Hospital Universitario Virgen del Rocío, Instituto de Biomedicina (IBIS / CSIC), Universidad de Sevilla, Sevilla, Spain
⁶Hematology Department. Institut Català d’Oncologia. Hospital Doctor Josep Trueta. Institut d'Investigació Biomèdica de Girona (IDIBGI), Universitat de Girona, Girona, Spain
⁷Hematology Department, Institut Català d'Oncologia-Hospital Duran i Reynals, IDIBELL, L'Hospitalet del Llobregat, Spain
⁸Hematology Department, Hospital Del Mar, Barcelona, ESP
⁹Oryzon Genomics SA, Cornella de Llobregat, Spain
¹⁰Oryzon Genomics SA, Boston, MA

Arjan A. Van de Loosdrecht, MD, PhD¹, Jacqueline Cloos, Prof^1*, Eva-Maria Wagner-Drouet, MD^2*, Uwe Platzbecker, MD³, Tobias A. W. Holderried, MD^4*, Catharina van Elssen, MD, PhD^5*, Aristoteles Giagounidis, MD⁶, Sören Lehmann⁷, Hester J.T. van Zeeburg, PhD^8*, Jeroen Rovers, MD, PhD^8* and Bjorn T. Gjertsen, MD, PhD⁹

¹Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, Netherlands
²Universitätsmedizin der Johannes Gutenberg-Universität, Mainz, Germany
³Universitätsklinikum Leipzig, Leipzig, Germany
⁴Universitaetsklinikum Bonn, Bonn, Germany
⁵Maastricht University Medical Centre, Maastricht, NLD
⁶Marien Hospital, Düsseldorf, Germany
⁷Uppsala University Hospital, Uppsala, Sweden
⁸Mendus AB, Stockholm, Sweden
⁹Haukeland University Hospital, Bergen, Norway

Hongtao Liu, MD, PhD¹, Elad Sharon, MD, MPH^2*, Theodore G. Karrison, PhD^3*, Yuanyuan Zha, PhD^4*, Noreen Fulton, BS^1*, Howard Streicher, MD^2*, Kendra Sweet, MD⁵, George Yaghmour, MD⁶, Jane Jijun Liu, MD^7*, Brian A. Jonas, MD, PhD⁸, Aaron D. Schimmer, MD, PhD⁹, Steven Grant, MD¹⁰, Amer M. Zeidan, MD¹¹, Gerhard C. Hildebrandt, MD¹², Christopher S. Hourigan, MD PhD¹³, Christopher H. Lowrey, MD¹⁴, Ryan J. Mattison, MD¹⁵, Neil Palmisiano, MD, MS¹⁶, Amandeep Salhotra, MD¹⁷, Dimitrios Tzachanis, MD, PhD¹⁸, Maria R. Baer, MD¹⁹, Tara L. Lin, MD²⁰, Prapti Patel, MD²¹, Helen Chen, MD^2*, Walter M. Stadler, MD^22*, Olatoyosi Odenike, MD¹, Richard A. Larson, MD²³, Thomas F. Gajewski, MD, PhD^1* and Wendy Stock, MD¹

¹Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
²Division of Cancer Treatment and Diagnosis, National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD
³Department of Public Health Sciences, University of Chicago, Chicago, IL
⁴HIM Facility at University of Chicago,, University of Chicago, CHICAGO, IL
⁵Department of Hematology and Oncology, Moffitt Cancer Center, Tampa, FL
⁶Division of Hematology, Department of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA
⁷Illinois CancerCare, Peoria, IL
⁸Department of Internal Medicine, Division of Malignant Hematology, Transplantation and Cellular Therapy, University of California Davis School of Medicine, Sacramento, CA
⁹Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
¹⁰VCU Massey Cancer Center, Richmond, VA
¹¹Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT
¹²Department of Internal Medicine, Division of Hematology/BMT, University of Kentucky, Lexington, KY
¹³Laboratory of Myeloid Malignancies, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD
¹⁴Dartmouth-Hitchcock Medical Center, Lebanon, NH
¹⁵Carbone Comprehensive Cancer Center, Madison, WI
¹⁶Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA
¹⁷Department of Hematology and HCT, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
¹⁸University of California San Diego, La Jolla, CA
¹⁹University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
²⁰Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas, Kansas City, KS
²¹Division of Hematology and Oncology, University of Texas Southwestern, Dallas, TX
²²Section of Hematology/Oncology, Department of Medicine, University of Chicago Medicine, Chicago, IL
²³Section of Hematology/Oncology, University of Chicago, Chicago, IL